newsfilter
← Latest News
Business Wire·

DiaMedica Therapeutics to Present at Jefferies Global Healthcare Conference 2025

DiaMedica Therapeutics Inc. (NASDAQ:DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for preeclampsia and acute ischemic stroke, today announced that Rick Pauls, President and